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Abstract
Background: To observe the survival of preterm infants with respiratory distress syndrome treated with bubble
CPAP in a tertiary care hospital.
Methods: This prospective observational study was conducted in the NICU of Civil hospital Sukkur from 1st July
2013 to 18th August 2015. All consecutively born preterm neonates with gestational age between 27 weeks to 36
weeks of gestation, admitted to the neonatal intensive care unit with respiratory distress are included in the study.
These neonates were managed by Bubble continuous positive airway pressure (bCPAP) in combination with
surfactant (bovine derivative) via intubation, Surfactant replacement, extubation (INSURE) protocol Success was
considered when neonates were clinically stable and required <0.3 FiO2 to maintain oxygen Saturation >90% and
PaCO2 <40-45 mmHg.
Results: Mean age of enrolled infants was 1.35 ± 0.60 days, 70 (57.9%) were males and 51 (42.1%) were
female, mean weight was 1.76 ± 0.37 kg and mean gestational age was 33 ± 2.3 weeks. Overall 77 (63.6%) preterm
infants were successfully weaned off from CPAP. Multivariable analysis showed weight of infant less than 1.5 kg or
8.63 (95% CI: 1.71-43.57), respiratory rate of more than 70 breaths per minute, or 9.59 (95% CI: 2.59-35.52), nasal
flaring or 3.35 (95% CI: 1.08-10.31) and typical findings of RDS on chest X-rays 12.04 (95% CI: 1.89-76.52) are
independent risk factors for failure of bCPAP. However, gestational age 0.70 (95% CI: 0.54-0.89) is protective
against failure.
Conclusion: bCPAP has a high proportion of success in the management of respiratory distress syndrome in
preterm. It could be most useful in resource-constrained settings.
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Introduction
Annually about 15 million preterm babies are born around the
world and more than one million die soon after birth mainly due to
respiratory complications [1,2]. Respiratory distress syndrome (RDS)
is a common and serious complication of preterm birth accounting for
50% cases [3,4] preterm, Therefore, it is the major cause of mortality in
preterm neonates [5]. Recent advances in the perinatal care have led to
the markedly improved survival of preterm infants during the last two
decades. Conventionally neonates with respiratory distress are
managed by respiratory support with positive pressure ventilation
(delivered usually by mechanical ventilator) and surfactant
replacement therapy [6]. Surfactant replacement via intubation,
surfactant replacement, and extubation to CPAP (INSURE) protocol
described by Verder et al. [7] in 1994, remarkably reduced the need for
mechanical ventilator from 85% to 41% in the preterm neonate. In the
developed world mechanical ventilator and CPAP machines are the
mainstays of respiratory support in neonates [6] but these machines
are too expensive and many resources constrained, low socioeconomic
countries [6]. The effectiveness of locally adapted bCPAP has been
documented [8,9]. bCPAP is a simple and cost effective respiratory
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support system (RSS) which consists of products that are easily
available and health care provider can easily be trained to make and
use this RSS [8]. bCPAP circuits consisted of inspiratory limb, the
interface (nasal prongs) and the proximal part of the expiratory limb.
The proximal end of the inspiratory limb connects the humidified
oxygen source (wall piped oxygen) through the interface to the baby
[8]. These tubes are carefully secured with an adhesive plaster to ensure
that the length immersed in water remains constant [8]. The bCPAP
generator is a cylindrical, transparent bottle filled to predetermined
level with distilled water. The expiratory limb of the circuit is
immersed in this bottle and the depth of the immersion in centimeters
below the water surface correspond to the desired bCPAP in cm H2O
usually between 5 cm to 8 cm of H2O [8]. This provides positive
pressure in the whole respiratory cycle [9], increases the functional
residual capacity of lungs and lowers work of breathing [10].
Ultimately, bCPAP reduces the need for mechanical ventilation,
morbidity, mortality [6-11]. Many studies have been shown that locally
manufactured bCPAP system showed promising results [9,12]. There is
a paucity of studies on the effectiveness of bCPAP in Pakistan. In this
study, we intend to observe the efficacy of Bubble CPAP with
surfactant replacement therapy in the management of RDS in preterm
neonates.
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Materials and Methods
This prospective observational study was conducted in the neonatal
intensive care unit (NICU) of Civil hospital Sukkur from 1st July 2013
to 18th August 2015. All consecutively born preterm neonates with
gestational age between 27 weeks to 36 weeks admitted with
respiratory distress have a characteristic chest radiographic appearance
i.e. uniform reticulogranular pattern with or without air bronchogram,
an arterial oxygen tension (PaO2) <50 mmHg and a requirement for
supplemental oxygen to maintain oxygen saturation over 85% were
included in this study. Infants with a gestational age more than 36
weeks or requiring mechanical ventilation at the time of admission or
having major congenital malformation including congenital
diaphragmatic hernia, trachea-esophageal fistula, cleft lip/palate;
chromosomal abnormalities such as trisomy [13-18], significant
morbidity besides RDS including cardiac diseases; parent refused to
participate in the study were excluded. Eligible infants were started on
bCPAP with bi-nasal prongs. Positive end-expiratory pressure (PEEP)
was started at 5 cm of H2O and was adjusted to minimized chest
retraction. FiO2 was adjusted to maintain SpO2 88% to 94%. Flow was
titrated to produce continuous bubbling in the chamber. Surfactant
(bovine derivative) was administered via intubation, surfactant
replacement, extubation (INSURE) protocol. If Fraction of Inspired
Oxygen (FiO2) requirement ≥ 0.4 then a dose of surfactant repeated
after 6 h to 12 h of the first dose for maximum three doses. bCPAP was
considered to be successful if neonate is clinically stable, respiratory
distress improved and the baby could be successfully weaned off from
bCPAP. Preterm infants with no subcostal recession, no nasal flaring,
the respiratory rate between 50 per min and 60 per min and O2
saturations of >90% on FiO2 <30% and PEEP <5 cm of water were
weaned off from bCPAP. Neonates were labeled as having CPAP failure
and were started on mechanical ventilator when they remained
hypoxic i.e. estimated arterial oxygen saturation (SpO2) <87% despite

FiO2 >70% and PEEP >7 cm of H2O; severe retraction on PEEP >7 cm
of H2O; prolong (>20 seconds) and recurrent apnea and partial
pressure of carbon dioxide (PaCO2) > 60 mmHg with pH <7.2 on two
consecutive arterial blood analysis within 30 min.
Data on age, birth weight, gestational age, gender, respiratory rate,
heart rate, nasal flaring, subcostal recession, typical findings of RDS on
chest X-ray chest were recorded by a doctor on pre-approved
proforma.
By taking a proportion of success of bCPAP 75% with a margin of
error 8% at 95% confidence interval the calculated sample size was 121
preterm neonates by using World Health Organization (WHO)
software for sample size calculation [14]. Data was entered and
analyzed using SSPS (SPSS Inc. Chicago, IL, USA) [18]. Mean and
standard deviation computed for quantitative variables including age,
birth weight, gestational age, respiratory rate and heart rate.
Frequencies and percentages were reported for categorical variables
including gender, nasal flaring, subcostal recession and chest X-ray
showing signs of RDS. Student t-test was used to compare continuous
variables and Chi-Square test applied to compare categorical variables.
A p-value of <0.05 will be taken as significant. Multivariable logistic
regression analysis was done to determine factors of failure of infants
treated with bCPAP. Model fit was assessed through Hosmer and
Lemeshow test. This study was approved by hospital ethical review
committee.

Results
Total 121 preterm infants were enrolled in the study. Mean age of
enrolled infants was 1.35 ± 0.60 days, 70 (57.9%) were males and 51
(42.1%) were female, mean weight was 1.76 kg ± 0.37 kg and mean
gestational age was 33 ± 2.3 weeks (Table 1).

Total

Failure

Success

(n=121)

(n=44)

(n=77)

1.35 ± 0.60

1.32 ± 0.6

1.36 ± 0.6

0.691

Male

70 (57.9%)

24 (54.5%)

46 (59.7%)

0.357

Female

51 (42.1%)

20 (45.5%)

31 (40.3%)

Mean weight (kg)

1.76 ± 0.37

1.56 ± 2.8

1.86 ± 0.38

<0.001

Mean gestational age (weeks)

33 ± 2.3

33.57 ± 2.5

32.68 ± 2.18

0.43

Mean respiratory rate (b/min)

64 ± 4.9

65 ± 5.2

61.86 ± 4.02

<0.001

Respiratory rate >70

76 (62.8%)

38 (86.4%)

38 (49.4%)

<0.001

Mean heart rate (b/min)

159.35 ± 8.3

159.11 ± 9.62

159.48 ± 7.62

0.818

Nasal flaring

71 (58.7%)

32 (72.7%)

39 (50.6%)

0.014

Subcostal recession

96 (79.3%)

41 (93.2%)

55 (71.4%)

0.003

Typical finding of RDS on chest X-rays

81 (66.9%)

42 (95.5%)

39 (50.6%)

<0.001

Mean age (in days)

P-value

Gender

kg- kilograms, b/min- breaths or beats per minute, RDS- respiratory distress syndrome.

Table 1: Baseline characteristics of infants.
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Crude or (95% CI)

Adjusted or (95% CI)

1.14 (0.61-2.13)

1.41 (0.54-3.67)

Female

1

1

Male

0.81 (0.38-1.71)

0.71 (0.23-2.11)

Weight of infant <1.5 kg

7.42 (2.48-22.12)

8.63 (1.71-43.57)

Mean gestational age (weeks)

0.84 (0.71-0.99)

0.70 (0.54-0.89)

Respiratory rate >70

6.5 (2.46-17.14)

9.59 (2.59-35.52)

Mean heart rate (b/min)

1.01 (0.96-1.05)

1.02 (0.95-1.09)

Nasal flaring

2.59 (1.17-5.78)

3.35 (1.08-10.31)

Subcostal recession

5.46 (1.53-19.51)

3.87 (0.54-27.40)

Typical finding of RDS on chest X-rays

20.46 (4.62-90.53)

12.04 (1.89-76.52)

Mean age (in days)
Gender

kg- kilograms, b/min- breaths or beats per minute, RDS- respiratory distress syndrome. CPAP-Continuous positive airway pressure, OR- odds ratio, CI- confidence
interval.

Table 2: Predictors of treatment failure among infants on bubble CPAP.
Of 121 infants, mean respiratory rate was 64 ± 4.9 breaths per min,
76 (62.8%) has respiratory rate of more than 70 breaths per min; mean
heart rate 159.35 ± 8.3 beats per minutes; 71 (58.7%) had nasal flaring,
96 (79.3%) has subcostal recession and 81 (66.9%) had typical X-ray
findings of RDS.
Overall 77 (63.6%) preterm infants were successfully weaned off
from bCPAP. Comparative analysis of preterm infants who successfully
wean off and who fail bCPAP is summarized above in (Table 2).
Univariable analysis showed the weight of the infant, gestational
age, respiratory rate of more than 70, nasal flaring, subcostal recession
and typical findings of RDS on chest X-ray are factors associated with
failure of bCPAP. Multivariable analysis showed weight of infant less
than 1.5 kg OR 8.63 (95% CI: 1.71-43.57), respiratory rate of more than
70 breaths per minute, or 9.59 (95% CI: 2.59-35.52), nasal flaring or
3.35 (95% CI: 1.08-10.31) and typical findings of RDS on chest X-rays
12.04 (95% CI: 1.89-76.52) are independent risk factors for failure of
bCPAP. However, gestational age 0.70 (95% CI: 0.54-0.89) is protective
against failure.

Discussion
We evaluated the effectiveness of bCPAP in the management of RDS
in the preterm neonate. The role of Bubble CPAP in the management
of RDS was emphasized by many researchers. Randomized controlled
trials also conducted in India and Australia in which they compared
the safety profile and effectiveness of bubble CPAP with a mechanical
ventilator in preterm infants. Neonates treated with Bubble CPAP were
more successful than mechanical ventilator [8]. Lee et al. [18] also
elicited the superiority of bCPAP in preterm neonates in comparison
to a mechanical ventilator. They also emphasized on the usefulness of
bCPAP in very low birth neonates [13]. In our study, only 44 neonates
out of 121 who were started on Bubble CPAP require mechanical
ventilation. Only 3 babies had pneumothorax which was successfully
managed. In a retrospective study by Ammari et al. [15], the failure
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rate of bCPAP was 24% in babies <1250 g and 50% in babies <750 g.
None of the baby >30 weeks gestation failed Bubble CPAP. The
difference between success rate with our study is due to we made
bubble CPAP which is most economical (manually device) while in the
study by Ammari et al. [15] used Fischer and Paykel bubble CPAP.
Another reason could be inadequate infection control in public sector
hospital. In a case-control study by Boo et al. [16] of the 97 preterm
babies with RDS on ventilator CPAP or bubble CPAP, 38% failed CPAP
and require mechanical ventilation [16].
Results of our study showed weight of infant less than 1.5 kg or 8.63
(95% CI: 1.71-43.57), respiratory rate of more than 70 breaths per min,
or 9.59 (95% CI: 2.59-35.52), nasal flaring OR 3.35 (95% CI:
1.08-10.31) and typical findings of RDS on chest X-rays 12.04 (95% CI:
1.89-76.52) are independent risk factors for failure of bubble CPAP.
However, gestational age 0.70 (95% CI: 0.54-0.89) is protective against
failure. Ammari et el. [15] reported typical findings of RDS on the
chest x-ray was an important predictor of bubble CPAP failure. In
other uncontrolled studies and in the studies comparing INSURE with
ventilation, CPAP failure rate ranges from 14% to 40%. Koti et al. [14]
conduct a retrospective analytical study on 56 neonates (28 weeks to 34
weeks) reported the failure of bubble CPAP of 25%.
The higher incidence of sepsis in our study is a lack of proper
facilities and trained staff for infection control. The higher rate of
CPAP failure in the study of Boo et al. [16] may be attributed to the
lesser use of surfactant. These differences are mainly due to the
paramedical care provided to the neonates and lesser incidence of
septicemia.
There are some limitations to the study. First, we did not account for
infections in these infants. However, blood cultures were negative in all
these infants. Second, this is a single-center study so results cannot be
generalized.
In conclusion, RDS is a potentially treatable problem of all preterm
infants. It can be treated by a mechanical ventilator or bCPAP along
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with surfactant replacement. In this study, we observe the success rates
of locally manufactured bubble CPAP in the management of RDS to
reduce morbidity, mortality and economic burden of this disease.
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